导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -17.65% | 960/1050 |
| 近一周 | -2.38% | 578/1104 |
| 近一月 | -2.90% | 338/1102 |
| 近一季 | -0.83% | 287/1092 |
| 近半年 | -14.09% | 868/1070 |
| 近一年 | -28.45% | 979/1018 |
| 近两年 | 4.81% | 868/926 |
| 近三年 | -28.43% | 805/834 |
| 成立以来 | 35.38% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-7.76% 942/1070 |
-14.52% 1010/1101 |
- - |
- - |
| 2025 | 2.79% 909/1065 |
4.53% 441/1014 |
9.74% 111/1038 |
0.17% 1003/1050 |
-10.55% 894/1065 |
| 2024 | 0.13% 577/1011 |
-0.57% 346/960 |
-10.96% 890/983 |
15.40% 208/991 |
-2.00% 450/1011 |
| 2023 | -26.50% 784/952 |
3.41% 412/880 |
-17.57% 870/895 |
-1.34% 128/915 |
-12.60% 906/952 |
| 2022 | -15.24% 181/867 |
-18.15% 435/773 |
17.52% 62/806 |
-15.02% 568/845 |
3.69% 255/867 |
| 2021 | -1.12% 366/740 |
-0.04% 152/580 |
9.73% 363/659 |
-13.20% 579/704 |
3.85% 267/740 |
| 2020 | 97.60% 38/554 |
-5.22% 296/419 |
30.65% 121/466 |
25.51% 17/517 |
27.14% 50/554 |
| 2019 | - - |
- - |
- - |
3.05% 253/390 |
6.90% 280/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 嘉实消费精选股票C VS. 东吴新产业精选股票A(580008) |